News by subject: TRI

Vanda Pharmaceuticals Inc. (Vanda) today announced the publication of an article titled "Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study" in the Journal of Clinical Psychiatry.1 The findings of this...

Showcasing wilate® at EAHAD 2024 WIL-31 is the largest...

Cardiff Oncology, Inc. , a clinical-stage...

iProcess Global Research, renowned for its leadership in clinical trial management and biospecimen collection, is excited to announce an expanded focus on Medical Device Trials. This initiative is part of their ongoing commitment to revolutionizing...

Vast Therapeutics announces publication of a manuscript in the journal of Antimicrobial Agents & Chemotherapy describing the utility of its novel nitric oxide-releasing drug candidate targeting infections caused by non-tuberculosis mycobacteria...

Immunity Pharma, a clinical-stage neurology-focused biopharmaceutical company, today announced positive...

RealTime Software Solutions, a leading provider of cutting-edge eClinical solutions for clinical research sites, proudly announces a year of remarkable growth and success in 2023, solidifying its position as the premier choice for clinical research...

FastWave Medical, a pioneering medical device company focused on differentiated approaches to addressing calcified cardiovascular disease through advanced intravascular lithotripsy (IVL) technology, is pleased to announce the successful completion...

...

Filament Health Corp. (Cboe CA: FH) ("Filament" or the "Company"), a clinical?stage natural psychedelic drug development company, today announced that it successfully completed an export of PEX010, the Company's botanical psilocybin drug candidate,...

Veeva Systems today announced a top 20 biopharma and Veeva Services migrated 25 ongoing clinical studies to Veeva Vault EDC from a legacy electronic data capture (EDC) application. This successful migration of an entire core study portfolio ?...

Ibezapolstat outperformed vancomycin showing eradication of fecal C. difficile at Day 3 of treatment in 15 of 16 treated patients (94%), versus vancomycin which had eradication of C. difficile in 10 of 14 treated patients (71%).Ibezapolstat, but not...

Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. , today announced that the final patient has been enrolled in its Phase I clinical trial.     Initiated on...

Exero Medical's prospective, blinded, multi-center study of xBar has been approved by the WCG. The study, expected to commence during...

Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular...

Medivir AB , a pharmaceutical company focused on developing innovative treatments for cancer in...

Leap...

The Canadian Myeloma Research Group (CMRG) is proud to announce the publication of groundbreaking clinical trial results in the prestigious medical journal Nature Medicine. The study, entitled "Belantamab mafodotin, pomalidomide and dexamethasone in...

A single ABBV-RGX-314 gene therapy treatment has the potential to become a new standard-of-care option among anti-VEGF treatments by sustaining vision health long term and overcoming the clinical challenges of managing wet AMD due to the treatment...

Tarsier Pharma, Ltd., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing first-in-class new therapies for the treatment of blinding ocular diseases, today announced it has received agreement from the U.S....

Intera Oncology, maker of the only FDA-approved implantable pump for Hepatic Artery Infusion (HAI) therapy, announces independent research on HAI therapy will be presented at the ASCO Gastrointestinal Cancers Symposium (ASCO GI) January 18-20 in San...

Raymond Douglas MD, PhD led a new study finding long term hearing loss is rare in those with normal audiometry at baseline following treatment with Tepezza [teprotumumab]. The results also showed with predictability that patients with preexisting...

AutoCruitment, a market leader in digital patient recruitment for clinical trials, announces that Jill Pellegrino has been appointed CEO and a member of the Board of Directors, and Co-Founders Bethany Bray (CEO) and Ben Cooper (COO) have transitioned...

Presage Biosciences, a biotechnology company whose mission is to enable precision drug response evaluation in the human tumor microenvironment (TME), announced that the U.S. Food and Drug Administration (FDA) has issued a Study May Proceed...

Saluda Medical, Inc., a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies, today announced the company's data will be presented at the North...

? Newly peer-reviewed, published research demonstrates the power of NetraAI to detect novel and known potential therapeutic targets for amyotrophic lateral sclerosis (ALS) that were not identified using other AI-based methods ? ? NetraAI identified...

Eisai announced today the presentation of gastrointestinal cancer research during the...

Precigen, Inc. , a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced...

W. L. Gore & Associates, Inc. (Gore) announced today that the first patients have been enrolled in the Gore VBX FORWARD Clinical Study...

Epitomee® announces the successful completion of the RESET pivotal clinical trial, for its weight loss capsule. The randomized placebo controlled, double blind trial, investigated the safety and efficacy of Epitomee® capsule versus the sham capsule...

Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment (LODOCO®-- colchicine, 0.5 mg tablets), together with Caristo Diagnostics, a leading cardiac disease diagnostics...

Cyrano Therapeutics, Inc., a regenerative medicine company pioneering the development of treatments for smell loss,...

In a first-in-human study, researchers at Orlucent, Inc. have demonstrated the viability of a novel handheld point-of-care molecular Skin Fluorescence Imaging (mSFI) System to noninvasively identify and clinically assess the presence of biological...

NRX-101 has demonstrated potent activity against resistant urinary pathogens upon FDA reviewQIDP designation grants Priority Review and an additional 5 years of additional product exclusivity 3 million Americans develop complicated Urinary Tract...

Results from a recent INC-funded intervention study were published in the American Journal of Clinical Nutrition [1]. The study showed that for older adults with overweight or obesity, longer-term consumption of mixed nuts significantly improved...

Chengdu Chipscreen NewWay Biosciences Co., Ltd. (NewWay) announced that on January 5, 2024, the dosing of the first patient for a phase I clinical trial of a PD-1/CD40 bispecific antibody (bsAb), NWY001, at Sun Yat-Sen University Cancer Center in...

STIC CTC trial data published this November 2023 in the Journal of Clinical Oncology (JCO) demonstrate that CTC-guided treatment decision confers superior survival benefits in a subgroup of patients with hormone receptor (HR) positive)/human...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that CT011, an autologous CAR T-cell product candidate against...

In this free webinar, learn about the Immunoscore Immune Checkpoint (CD8/PDL1) assay. Experts will provide an in-depth review of the assay's analytical performance, clinical relevance and efficacy, with a focus on metastatic colorectal cancer (mCRC)...

Medivir AB , a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that clinical pharmacokinetic (PK) data from the first study with fostroxacitabine bralpamide (fostrox)...

Hope Medicine Inc. ('HopeMed'), a clinical-stage innovative biopharmaceutical company, announced recently that the company has completed a Phase Ib study, "An Open-Label Study, to Evaluate Safety, Tolerability, and Efficacy in Male and Female with...

RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, announced recently that its independently developed mesothelin (MSLN)-targeting antibody-drug conjugate (ADC), RC88, has been granted Fast...

ClinChoice, a leading global Contract Research Organization (CRO), today announced expanding its global footprint with the acquisition of CSI Medical Research (CSI). CSI is a regional clinical CRO with professional staff and partners located across...

U.S. organ procurement organizations (OPOs) recovered 43,000 organs that resulted in life-saving transplants in 2023, according to recently released data from the Organ Procurement and Transplantation Network. This milestone accounts for an average...

A recent Position Paper from the American College of Clinical Pharmacology® (ACCP) entitled "Inclusion of Obese Participants in Drug Development: Reflections on the Current Landscape and a Call for Action" was published in The Journal of Clinical...

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, today announced the acquisition of Galvanize Therapeutics' Electrophysiology Technology division. Notable assets included in the acquisition...

Endovascular Engineering ("E2"), a medical device company focused on the development and deployment of groundbreaking clot removal technologies that target venous thromboembolism (VTE), announced today FDA Investigational Device Exemption (IDE)...

New analysis of data published by Susan Halabi, PhD, of Duke University could facilitate approval of new prostate cancer treatments almost two years earlier than the current standard. The study published online January 5, 2024, in the Journal of...

Scientists have long known that some viruses and bacteria begin infections by latching first onto sugar molecules on the surfaces of cells lining the sinuses and throat of mammals, including humans. Viral particles, for instance, can attach to these...

The presence of plastics in our oceans and waterbodies is one of the most significant threats to marine ecosystems. In 2022, plastic production exceeded 400 million tons globally, and this number continues to rise. The presence of microplastics,...